ProJectPharmaceutics @ProJectPharma

ProJect Pharmaceutics transforms proteins, peptides and ADCs / cytotoxics into pioneering drugs. project-pharmaceutics.com Germany Joined October 2011

Tweets

53
Followers

352
Following

507
Likes

0

ProJectPharmaceutics @ProJectPharma

3 years ago

#ADC #formulation lnkd.in/e4waJDT7

0 0 1 27 0

ProJectPharmaceutics @ProJectPharma

3 years ago

lnkd.in/evT5UPg6

0 0 0 22 0

ProJectPharmaceutics @ProJectPharma

3 years ago

lnkd.in/eHBKwYJE

0 0 0 22 0

ProJectPharmaceutics @ProJectPharma

3 years ago

lnkd.in/e5GGzDPk

0 0 0 0 0

ProJectPharmaceutics @ProJectPharma

3 years ago

#lyophilization #lyocycle lnkd.in/guUW7XiC

0 0 0 0 0

ProJectPharmaceutics @ProJectPharma

3 years ago

lnkd.in/esSw7Wza

0 0 0 0 0

ProJectPharmaceutics @ProJectPharma

3 years ago

#biologics #pharma #protein lnkd.in/ef22ifv8

0 0 0 0 0

ProJectPharmaceutics @ProJectPharma

3 years ago

The molar extinction coefficient needs to be experimentally determined for drug products. We are able to determine it using an absolute gravimetric determination approach. Thereby we consider the protein primary sequence as well as glycosylation for the overall protein mass.

0 0 0 0 0

Download Image

ProJectPharmaceutics @ProJectPharma

3 years ago

lnkd.in/etwkNXKh

0 0 0 0 0

ProJectPharmaceutics @ProJectPharma

3 years ago

lnkd.in/exFV3xvz

0 0 0 0 0

ProJectPharmaceutics @ProJectPharma

7 years ago

Meet us and learn more about our formulation and process development capabilities for proteins, cytotoxics, viruses, #ADCs and other sensitive APIs at CPhI Worldwide in Madrid, October, 9-11, booth 14.1 D 92

0 0 0 0 0

Download Image

ProJectPharmaceutics @ProJectPharma

8 years ago

Project Pharmaceutics expands its safety facilities for formulation and lyophilization cycle development to handle live virus vaccines, protective and therapeutic vaccines, as well as gene and cell therapy products (GMO S2 / BSL-2). Please check out project-pharmaceutics.com/services/live-…

0 0 0 0 0

ProJectPharmaceutics @ProJectPharma

9 years ago

Talk announcement: “State-of-the-art QbD-based formulation development for ADCs” by Dr. D. Woide, at #WorldADC Berlin, Feb., 21, 2017, 13:00

0 0 0 0 0

ProJectPharmaceutics @ProJectPharma

9 years ago

Meet us and learn more about our formulation development capabilities for #ADCs at #WorldADC in Berlin, Feb., 21-22, project-pharmaceutics.com

0 1 0 0 0

ProJectPharmaceutics @ProJectPharma

10 years ago

Learn about PJP's unique ADC formulation development capabilities at ADCs & Cancer Immunotherapy, Vienna, Feb. 25-26 project-pharmaceutics.com/services/cytot…

0 0 0 0 0

ProJectPharmaceutics @ProJectPharma

10 years ago

Science-based approach for best-in-class high protein concentration formulations (liquid/lyo) for prefilled syringes project-pharmaceutics.com/services/high-…

0 1 0 0 0

ProJectPharmaceutics @ProJectPharma

10 years ago

Innovative high concentration protein formulations: PDA "The universe of pre-filled-syringe", Wien, Nov., 3-4, 2015, project-pharmaceutics.com/services/

0 0 0 0 0

ProJectPharmaceutics @ProJectPharma

11 years ago

Dr. Andreas Schütz's presents: “Formulation and lyophilization process development for biopharmaceutics” at Bio Korea 2015, April 8, 15:30

0 1 0 0 0

ProJectPharmaceutics @ProJectPharma

11 years ago

PJP presents innovative formulation development strategies at Forum Life Science 2015 by @BayernInnovativ; project-pharmaceutics.com

0 1 0 0 0

ProJectPharmaceutics @ProJectPharma

11 years ago

Meet us and learn about our formulation development capabilities for #ADCs at #WorldADC in Frankfurt, Feb., 23-25, project-pharmaceutics.com/services/cytot…